629 related articles for article (PubMed ID: 26615369)
1. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
Stevens WW; Ocampo CJ; Berdnikovs S; Sakashita M; Mahdavinia M; Suh L; Takabayashi T; Norton JE; Hulse KE; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Kato A; Harris KE; Carter RG; Fujieda S; Kern RC; Schleimer RP
Am J Respir Crit Care Med; 2015 Sep; 192(6):682-94. PubMed ID: 26067893
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
[TBL] [Abstract][Full Text] [Related]
4. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
Sohail A; Hacker J; Ryan T; McGill A; Bergmark R; Bhattacharyya N; Lee SE; Maxfield A; Roditi R; Julé AM; Griffith A; Lederer J; Laidlaw TM; Buchheit KM
J Allergy Clin Immunol; 2024 Feb; 153(2):527-532. PubMed ID: 37898408
[TBL] [Abstract][Full Text] [Related]
5. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4.
Celejewska-Wójcik N; Mastalerz L; Wójcik K; Nieckarz R; Januszek R; Hartwich P; Szaleniec J; Hydzik-Sobocińska K; Oleś K; Cybulska A; Stręk P; Sanak M
Pol Arch Med Wewn; 2012; 122(9):422-7. PubMed ID: 22814420
[TBL] [Abstract][Full Text] [Related]
6. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
7. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
8. Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.
Nordström A; Jangard M; Svedberg M; Ryott M; Kumlin M
Prostaglandins Leukot Essent Fatty Acids; 2022 Sep; 184():102474. PubMed ID: 35917595
[TBL] [Abstract][Full Text] [Related]
9. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
10. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD).
Priyadharshini VS; Jiménez-Chobillon MA; de Graaf J; Porras Gutiérrez de Velasco R; Gratziou C; Ramírez-Jiménez F; Teran LM
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439758
[TBL] [Abstract][Full Text] [Related]
12. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
13. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease.
Machado-Carvalho L; Martín M; Torres R; Gabasa M; Alobid I; Mullol J; Pujols L; Roca-Ferrer J; Picado C
J Allergy Clin Immunol; 2016 Jan; 137(1):99-107.e7. PubMed ID: 26560040
[TBL] [Abstract][Full Text] [Related]
14. IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.
Buchheit KM; Dwyer DF; Ordovas-Montanes J; Katz HR; Lewis E; Vukovic M; Lai J; Bankova LG; Bhattacharyya N; Shalek AK; Barrett NA; Boyce JA; Laidlaw TM
J Allergy Clin Immunol; 2020 Jun; 145(6):1574-1584. PubMed ID: 32199912
[TBL] [Abstract][Full Text] [Related]
15. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
[TBL] [Abstract][Full Text] [Related]
16. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
[TBL] [Abstract][Full Text] [Related]
17. Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis.
Choby G; Low CM; Levy JM; Stokken JK; Pinheiro-Neto C; Bartemes K; Marino M; Han JK; Divekar R; O'Brien EK; Lal D
Otolaryngol Head Neck Surg; 2022 Feb; 166(2):224-232. PubMed ID: 33973823
[TBL] [Abstract][Full Text] [Related]
18. Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients.
Choby G; O'Brien EK; Smith A; Barnes J; Hagan J; Stokken JK; Strumpf A; Mattos JL; Payne SC; Divekar R
Laryngoscope; 2021 May; 131(5):961-966. PubMed ID: 33001452
[TBL] [Abstract][Full Text] [Related]
19. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
[TBL] [Abstract][Full Text] [Related]
20. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E
Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]